Key statistics
As of last trade Innate Pharma SA (IDDA:FRA) traded at 2.00, 8.70% above its 52-week low of 1.84, set on Aug 05, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.00 |
---|---|
High | 2.00 |
Low | 2.00 |
Bid | 1.93 |
Offer | 2.16 |
Previous close | 1.92 |
Average volume | 0.00 |
---|---|
Shares outstanding | 80.97m |
Free float | 62.13m |
P/E (TTM) | -- |
Market cap | 185.25m USD |
EPS (TTM) | -0.4704 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 08:59 BST.
More ▼
Press releases
- Innate Pharma Reports First Half 2024 Business Update and Financial Results
- Innate Pharma SA: Monalizumab Data From NeoCOAST-2 Phase 2 Study in Early-Stage NSCLC Presented at the WCLC 2024
- Innate Pharma Announces Conference Call and Webcast for First Half 2024 Financial Results and Business Update
- Innate Pharma Announces Its Participation in the H.C. Wainwright 26th Annual Global Investment Conference
- Innate Pharma Announces Its Participation in Upcoming Investor Conference
- Number of Shares and Voting Rights of Innate Pharma as of July 10, 2024
More ▼